dipyridamole has been researched along with Psychotic Disorders in 2 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Psychotic Disorders: Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| BARCIASALORIO, D | 1 |
| BORREGUERO, AD | 1 |
2 other studies available for dipyridamole and Psychotic Disorders
| Article | Year |
|---|---|
[STUDY OF CEREBRAL HEMODYNAMICS IN THE DEPRESSIVE STATES].
Topics: Amitriptyline; Bipolar Disorder; Cerebrovascular Circulation; Depression; Depressive Disorder; Depre | 1963 |
[TREATMENT OF DEPRESSION WITH PERSANTIN].
Topics: Bipolar Disorder; Convulsive Therapy; Depression; Depressive Disorder; Dipyridamole; Electroconvulsi | 1964 |